- High gross margin of 92.4%
- Beat earnings estimates in 3 of the last 4 quarters
- Highly efficient cash conversion (102% FCF/OCF ratio)
Big movements in TScan Therapeutics, Inc. stock price on Monday moving 11.76% between high and low
(Updated on Jun 22, 2026)
The TScan Therapeutics, Inc. stock price fell by -5.97% on the last day (Monday, 22nd Jun 2026) from $0.92 to $0.87. During the last trading day the stock fluctuated 11.76% from a day low at $0.85 to a day high of $0.95. The price has been going up and down for this period, and there has been a -11.9% loss for the last 2 weeks. Volume has increased on the last day by 1 million shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 2 million shares were bought and sold for approximately $1.40 million.
The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $0.84 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -10.19% during the next 3 months and, with a 90% probability hold a price between $0.755 and $1.19 at the end of this 3-month period.
TCRX Signals & Forecast
A buy signal was issued from a pivot bottom point on Tuesday, June 16, 2026, and so far it has risen 2.00%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The TScan Therapeutics, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.90 and $1.04. A break-up above any of these levels will issue buy signals. TScan Therapeutics, Inc. gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".
Support, Risk & Stop-loss for TScan Therapeutics, Inc. stock
TScan Therapeutics, Inc. finds support from accumulated volume at $0.85 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.1000 between high and low, or 11.76%. For the last week, the stock has had daily average volatility of 9.64%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (TCRX) For The Upcoming Trading Day Of Tuesday 23rd
For the upcoming trading day on Tuesday, 23rd we expect TScan Therapeutics, Inc. to open at $0.89, and during the day (based on 14 day Average True Range), to move between $0.83 and $0.90, which gives a possible trading interval of +/-$0.0758 (+/-9.16%) up or down from last closing price. If TScan Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 9.16% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $0.85 (1.97%) than the resistance at $1.02 (17.91%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is TScan Therapeutics, Inc. stock A Buy?
TScan Therapeutics, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.
Current score:
-4.664
Sell Candidate
Unchanged
Predicted Fair Opening Price
Predicted fair opening price on June 23, 2026 - $0.89 ( 2.69%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
TCRX Performance
Trading levels for TCRX
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 0.99 | 14.25% |
| R2 | 0.95 | 9.83% |
| R1 | 0.93 | 7.11% |
| Price | 0.87 | |
| S1 | 0.85 | -1.73% |
| S2 | 0.83 | -4.45% |
| S3 | 0.788 | -8.87% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 1.07 | 23.69% |
| R2 | 1.06 | 22.53% |
| R1 | 1.02 | 17.91% |
| Price | 0.87 | |
| S1 | 0.85 | -1.97% |
| S2 | 0 | - |
| S3 | 0 | - |
FAQ
Click here for our free guide on how to buy TScan Therapeutics, Inc. Stock.
Buy TCRX